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Abstract Vessel growth is often associated with ischemia. 
VEGF, a potent angiogenic factor, has been shown to be induced 
by low oxygen concentrations. These studies were conducted to 
investigate the molecular basis of the hypoxia-induced increase 
in VEGF mRNA. Run-on analysis of VEGF revealed a minimal 
increase in the rate of gene transcription in a human retinal 
epithelial cell line grown under hypoxic conditions. Examination 
of VEGF mRNA stability revealed that the half-life of VEGF 
transcripts under normoxia was short, 30-45 min, but was dra- 
matically increased to 6-8 h in cells grown under hypoxia. Cobalt 
chloride, which elevates VEGF and has been suggested to be 
similar to hypoxia in its mechanism of action, had only a slight 
effect on decay rate. We postulate that hypoxia-induced increases 
in mRNA stability provide the sustained increases in VEGF 
mRNA levels necessary to support a neovascular response. 
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1. Introduction 
Vascular endothelial cell growth factor (VEGF) is a polypep- 
tide that has potent effects on the vascular system, including the 
ability to induce new vessel growth [1] and increase vascular 
permeability [2]. Data from a number of laboratories indicate 
that VEGF can be regulated by local oxygen concentrations i  
both transformed [3] and normal primary-cultured cells [4]. In 
addition, we have shown that hypoxia increases VEGF mRNA, 
protein synthesis, ecretion and bioactivity in primary cultures 
of human pigment epithelial cells (hRPE) [4]. The finding that 
a vascular growth factor can be regulated by local oxygen 
concentrations has obvious physiologic implications. Reduced 
oxygen tension is a characteristic of virtually all circumstances 
in which new vessel growth is observed. Although solid tumors 
are highly vascularized, it has been well-documented that the 
immature architecture of tumor blood vessels, coupled with 
their high level of permeability, leads to local collapse of tumor 
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vasculature with resulting hypoxia [5]. In addition, cell growth 
in some tumors such as glioblastomas is so rapid that tumor 
volume xceeds the perfusion capacity of the vasculature. Sim- 
ilarly, wounds have been shown to have a low oxygen environ- 
ment, with wound fluid being effectively anoxic [6]. 
Ischemia, with its concomitant hypoxia, has also been impli- 
cated in the development of new blood vessels which are a 
component ofdiabetes and retinopathy ofprematurity [7,8]. In 
an experimental model in which a primate retina was rendered 
ischemic by vein occlusion, there was reproducible develop- 
ment of new blood vessels. We have shown that the levels of 
VEGF in these animals correlate temporally, spatially and 
quantitatively with the extent of ocular neovascularization [9].
Moreover, ischemia-associated ocular angiogenesis in humans 
has been correlated with increased levels of VEGF [10,11]. 
In an effort to gain further insight into the regulation of 
VEGF by hypoxia, we have undertaken studies to determine 
the mechanism whereby hypoxia induces an increase in steady 
state levels of VEGF mRNA.  A well-studied paradigm for 
hypoxic regulation of gene expression is erythropoietin, where 
studies have focused primarily on the transcriptional activation 
and have led to the identification of a 3' cis-acting element that 
confers hypoxic regulation [12]. There are reported similarities 
between VEGF and erythropoietin regulation. For instance, 
both genes are up-regulated by exposure to cobalt chloride, a 
phenomenon attributed to the interaction ofcobalt with a puta- 
tive heme-binding oxygen sensor [13]. We initiated these stud- 
ies, hypothesizing that the oxygen regulation of VEGF might 
parallel that of erythropoietin. However, we found virtually no 
increase in the transcriptional r te of VEGF following hypoxic 
exposure of human retinal pigment epithelial cells and instead 
observed a dramatic increase in VEGF mRNA stability follow- 
ing hypoxia. 
2. Experimental 
2.1. Cell lines and hypoxia protocol 
Normal hRPE were isolated from donor eyes by enzymatic dissocia- 
tion and used between passages 3-6 as described [4]. An immortalized 
hRPE cell line (tRPE), created by stable integration of a CMV-driven 
SV40 large T-antigen expression cassette, was established asdescribed 
by others [14,15]. C6 astrocytoma and a mouse mammary epithelial cell 
line (C127I) were obtained from the American Tissue Culture Collec- 
tion. hRPE, tRPE and C6 astrocytoma were cultured in Dulbeccos' 
modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS), 
and penicillin and streptomycin. Mammary epithelial cells were cul- 
tured in DMEM with glucose supplement to 4.5 g/l. All cell lines were 
propagated in standard 10% CO2, 21% 02 incubators at 37°C. All tissue 
culture reagents were obtained from Sigma Chemical Co. (St. Louis, 
MO). 
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An hypoxic environment was created by incubating the cells in a 
standard 10% CO2 incubator infused with N2 gas to create a constant 
2% 02 environment, as monitored by a Pro:ox oxygen regulator and 
sensor (Reming Bioinstruments, Redfield, NY). Normoxia is defined 
as 21% 02 environment supplemented with 10% C02. All experiments 
were performed using confluent cell cultures. 
2.2. Northern blot analysis 
Total RNA was isolated from cultured cells by the modified acid- 
phenol method of Chomczynski and Sacchi [16], using RNAzol B 
(Tel-test). Fifteen micrograms of RNA/sample were fractionated by 
denaturing electrophoresis, and capillary blotted to charged nylon (Ge- 
nescreen Plus, DuPont). Prehybridization a d hybridization were car- 
ried out in 6 x SSPE, 5 × Denhardt's, 50% formamide, 1% SDS and 
100 #g/ml sheared, denatured salmon sperm DNA. A 520 bp NcoI/ 
BgllI fragment of the human VEGF cDNA (a gift of Dr. Herbert 
Weich, Gesellschaft f. biotechnol. Forschung, Braunschweig, Ger- 
many), a 575 bp fragment encompassing the entire coding region of 
mouse VEGF-1 (provided by Georg Breier, Max Planck Institute, Bad 
Nauheim, Germany) [17]), a 400 bp fragment of large T-antigen, a 400 
bp fragment encompassing the 3'UTR of the human fl-actin cDNA [18] 
and a 280 bp fragment of bovine 28S ribosomal RNA were used to 
generate random-prime labeled probes for hybridizations [19]. After 
washing, blots were exposed to Kodak XAR-5 film with intensifying 
screens at -80°C. Quantification of autoradiographs was carried out 
with a phosphorimager using Image Quant software (Molecular Dy- 
namics) and fl-actin or 28S rRNA for normalization. 
2.3. Nuclear run-on analysis of transcription 
Transcriptional ctivation of the VEGF gene in confluent cultures 
of tRPE was examined by run-on analysis after normoxic, hypoxic, or 
phorbol ester (TPA; 100 nM) treatment ofthe cells for designated times. 
Cells and all reagents were kept on wet ice or at 4°C throughout the 
duration of the experiment. Cells (5 x 107/condition) were washed with 
ice-cold PBS and nuclei were directly scrape-isolated into NP-40 lysis 
buffer (10 mM Tris pH 7.4, 10 mM NaC1, 3 mM MgC12, 0.5% NP-40 
(v/v). Cells were pelleted at 300 x g and gently resuspended in 20 ml lysis 
buffer. Cell membranes were disrupted by 15 strokes of a prechilled 
Dounce homogenizer (type 'B' loose pestle). Nuclei were isolated by 
centrifugation (300 x g) and washed in 50 volumes of wash buffer (lysis 
buffer with 0.025% NP-40). After centrifugation, pelleted nuclei were 
resuspended in freeze buffer (20 mM Tris, pH 8.0, 75 mM NaC1, 0.5 
mM EDTA, 1 mM DTT, and 50% glycerol), an aliquot examined by 
microscopy to confirm homogeneity and integrity of the preparation 
and the remaining samples were flash frozen in liquid N2 at a concentra- 
tion of 2-3 x 108 nuclei/ml, and stored at -80°C. 
RNA synthesis in vitro was performed in the presence of approxi- 
mately 2 x 10 7 nuclei in a reaction mixture of 50 mM Tris, pH 8.0, 5 
mM MgC12, 100 mM KC1, 1 mM DTT, 40 U Rnasin, 200/tM each of 
ATP, CTP and GTP, 200 #Ci UTP (3000 Ci/mmol; New England 
Nuclear, Boston, MA) for 30 min at 26°C. Under these conditions, the 
rate of transcription is linear, as determined by parallel hybridizations 
with 5-fold dilutions of RNA probe (data not shown). Nascent labeled 
RNA was isolated by DNase digestion (25 U; 30 min at 37°C), pro- 
teinase K digestion (200/zg/ml) in 0.5% SDS for 60 min at 37°C, 
followed by hot phenol/chloroform extraction and repeated ethanol 
precipitation i  2.5 M ammonium acetate. Target DNA filters (Ge- 
nescreen Plus, DuPont) were prepared by denaturation, eutralization 
and immobilization of 10 #g of linearized plasmid DNA harboring: a
520 bp fragment of human VEGFI65 (see above), a 400 bp fragment of 
the human fl-actin 3' untranslated region (see above), a 1 kb fragment 
of the human basic FGF cDNA [4] and pBluescript II as a negative 
control. 
Hybridizations were performed with 2 x 10 7 cpm/ml  of labeled RNA 
in 5 x SSPE, 50% deionized formamide, 2.5 x Denhardt's, and 0.25% 
SDS for 40 h at 42°C. Filters were washed twice in 2 x SSPE, 0.1% SDS 
for 1 h at 50°C, rinsed then incubated 1h in 2 x SSPE with 10/2g/ml 
RNase A, followed by two washes in 2× SSPE, 0.1% SDS for 1 h at 
65°C. Filters were briefly dried and exposed to film with intensifying 
screens for 96 h at -80°C. Alternatively, filters were analyzed with a 
phosphorimager screen and results quantified using ImageQuant soft- 
ware. Results described are representative of 4 similar experiments in
which time points ranging from 2 to 15 h of hypoxia treatment were 
examined. 
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Fig. 1. Hypoxic induction of VEGF mRNA levels in epithelial cells. (A) 
hRPE were cultured for 6, 12 or 24 h in normoxia nd hypoxia, and 
total RNA analyzed by Northern blot for VEGF mRNA. The same 
blot was stripped and hybridized with a 28S rRNA probe. (B) An 
immortalized hRPE cell line (tRPE) and a (C) mammary epithelial cell 
line were cultured for 15 h in normoxia or hypoxia, and total RNA 
analyzed for VEGF mRNA levels. Blots were stripped and hybridized 
with a T-antigen (B), and fl-actin (B,C) cDNA probe. 
2.4. Actinomycin D chase studies 
Confluent cells were incubated in a normoxic or hypoxic 
environment, or in the presence of cobalt chloride (100/.tM) for 
15 h. The cells were then rinsed and refed with culture media 
containing actinomycin D (5/.tg/ml) and incubated for an addi- 
t ional 1-8 h in standard culture conditions. Total RNA was 
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extracted and analyzed for VEGF and actin mRNA levels (see 
above), mRNA levels were quantified using a phosphorimager 
and ImageQuant software. These experiments were performed 
at least twice and representative results are shown. 
3. Results 
3.1. Effects of hypoxia on VEGF mRNA 
VEGF mRNA levels in normal hRPE were elevated at least 
10-fold after being cultured for 6 h in low oxygen and the steady 
state levels o fVEGF mRNA continued to increase throughout 
the time course examined (up to 24 h) (Fig. 1A). As has been 
previously reported, two transcripts were observed (approx 3.8 
and 4.0 kb) and most likely correspond to two of the four 
described alternatively spliced forms of VEGF mRNA. VEGF 
mRNA levels were similarly elevated in an immortalized 
human tRPE cell line (Fig. 1 B) cultured under hypoxic condi- 
tions and in a mouse mammary epithelial cell line (data not 
shown). To date, all adherent cell types tested (more than 15 
total) respond to hypoxia with an increase in VEGF mRNA. 
The exception ismost endothelial cells, in which VEGF mRNA 
is undetectable. In contrast, fl-actin mRNA (Fig. 1B; lanes 1 
and 2), 28S rRNA (Fig. 1A; lanes 1-6) and T-antigen mRNA 
(Fig. 1B; lanes 1 and 2) levels in the various cell lines were not 
altered upon exposure to hypoxia. 
The effects of hypoxia on VEGF gene expression are repro- 
ducibly detectable 3 h after the cells have been placed in an 
hypoxic environment; and there is continued accumulation of 
VEGF mRNA over the 15 h of a typical experiment (Fig. 2). 
The levels of VEGF mRNA induced by hypoxia, as well as that 
constitutively produced under normoxia, are dependent on 
protein synthesis ince the addition of 10 ¢tg/ml cycloheximide 
substantially decreased the levels of VEGF transcript levels in 
cells in normoxia or hypoxia for 15 h. 
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Fig. 2. Time course of hypoxic induction of VEGF mRNA levels and 
dependence on protein synthesis, tRPE were cultured for 0, 1, 3, and 
15 h in hypoxia, or for 15 h in normoxia nd hypoxia +/- the addition 
of 10 pg/ml cycloheximide. The same blot was analyzed for ]~-actin 
mRNA levels. The migration of 28S rRNA is marked. 
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Fig. 3. Effect of hypoxia on VEGF transcriptional activity. (A) tRPE 
were incubated for 3 and 15 h in normoxic or hypoxic culture condi- 
tions, times when hypoxia-induced increases in VEGF mRNA are ob- 
served (see Fig. 2). Radiolabeled run-on RNA's were synthesized from 
isolated nuclei and hybridized to immobilized cDNA's for VEGF, 
bFGF, and actin. Background hybridization was assessed by hybridiza- 
tion of probes to a vector (pBSII) negative control. (B) For a positive 
control, tRPE exposed to phorbol ester (TPA) for 2 h were used in 
run-on analysis of VEGF and actin transcription. 
3.2. Effect of hypoxia on the transcriptional rate of  the VEGF 
gene 
The current paradigm for hypoxic regulation of mammalian 
genes is provided by erythropoietin. Growth of the human 
hepatoma cell line HEP3B under hypoxic conditions leads to 
a 50-fold increase in steady state levels of erythropoietin 
mRNA [20]. Transcriptional ctivation of the erythropoietin 
gene has been a primary focus for understanding hypoxic reg- 
ulation of erythropoietin gene expression, although an ill-de- 
fined role for mRNA stability has been suggested [21]. There- 
fore, to characterize of the cellular mechanisms regulating hy- 
poxic induction of VEGF, tRPE cells grown for various time 
periods in normoxic or hypoxic conditions were used for nu- 
clear run-on analysis. The apparent ranscriptional rate for 
VEGF was compared to that for bFGF and the ]J-actin gene, 
which are not elevated in response to hypoxia [4]. Levels of 
baseline transcription assessed by hybridization of nascent, ra- 
diolabeled transcripts to immobilized cDNA's, varied slightly 
for the three genes studied but was significantly higher than 
background, non-specific probe hybridization to the vector 
control (Fig. 3A). In contrast o our expectations, levels of 
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VEGF transcripts in the run-on analysis howed little change 
during exposure of cells to hypoxia for 3 or 15 h, time points 
that correspond to periods in which VEGF mRNA levels are 
increasing (see Figs. 1A and 2). The most significant increase 
in the levels of VEGF transcripts ever detected in this assay 
(n=4) (approx 2.0 fold) was seen at 15 h of hypoxia, but this 
increase is also accompanied by similar increases in transcrip- 
tion for fl-actin and bFGF. Thus, the slight increase seen in 
VEGF transcription at this late time point is not likely to be 
a specific response to hypoxia. Similar results were obtained 
when run-ons were conducted with cells grown in hypoxia for 
2, 4, 6 and 12 h (data not shown). Phorbol ester treatment 
increases AP-l-mediated transcriptional ctivation of many 
genes, and has also been demonstrated to elevate VEGF 
mRNA levels [22,23]. To confirm that the assay utilized could 
detect elevation of VEGF transcription, 12 O-tetradecanoyl 
phorbol-13-acetate (TPA) treatment (2 h) was used as a positive 
control and was observed to lead to an approximately 4-fold 
increase in the VEGF transcriptional rate (Fig. 3B). Taken 
together, these data support a minimal role for transcriptional 
activation in the 10-15 fold induction of VEGF mRNA during 
hypoxia. 
3.3. Effect of hypoxia on VEGF mRNA stability 
The most likely alternative mechanism for regulation of 
VEGF mRNA by hypoxia is an increase in mRNA stability. 
Thus, actinomycin D chase studies were used to assess the rate 
of VEGF mRNA decay after exposure of tRPE to 15 h of 
normoxia or hypoxia. The efficacy of the actinomycin D treat- 
ment was assessed by quantifying incorporation of [3H]UTP 
into total RNA. Results of these analyses indicated that more 
than 95% of RNA synthesis was inhibited over the time course 
of the study. The '0' point represents he level of VEGF mRNA 
following 15 h of culture in normoxia or hypoxia. As expected, 
mRNA from tRPE grown in low oxygen was significantly ele- 
vated (15-fold) compared to mRNA levels from cells grown 
under normoxic conditions (Fig. 4A). In the absence of tran- 
scription, VEGF mRNA from cells cultured in normoxia de- 
cays rapidly and is nearly undetectable by 2 h of the chase 
period. Examination of a more detailed time course revealed 
that VEGF mRNA was undetectable 1-2 h after cessation of 
transcription (data not shown). Unstable mRNA is a common 
characteristic of many growth-associated proteins such as 
onco-proteins and cytokines [24]. The relative instability of the 
VEGF transcripts i highlighted by comparison with the rela- 
tively stable mRNA offl-actin (Fig. 4A). 
In contrast to the rapid decay of VEGF mRNA observed in 
cells cultured in normoxia, growth of cells in hypoxia led to a 
relative stabilization of VEGF mRNA, which remain constant 
until between 6-8 h, when a slight decrease (approx. 50%) was 
observed (Fig. 4). Overexposure of the blot examining VEGF 
mRNA stability in cells cultured under normal oxygen allowed 
detection of VEGF mRNA at 2 and 4 h following actinomycin 
D and was used for quantification and comparison of relative 
VEGF levels. A plot comparing relative mRNA levels as a 
function of time conveys the disparate rates of decay for VEGF 
mRNA under hypoxic versus normoxic ulture conditions (Fig. 
4C). The dramatic stabilization ofVEGF mRNA in cells grown 
under hypoxic conditions represents a difference which could 
reasonably account for the elevated steady state VEGF levels 
during hypoxia. 
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Fig. 4. (A) Effect of hypoxia on VEGF mRNA stability, tRPE were 
cultured in normoxic or hypoxic conditions for 15 h (time '0') and 
actinomycin D (5 pg/ml) was added to inhibit RNA synthesis. Cells 
were then incubated under normal culture conditions for 2, 4, 6 or 8 h, 
and VEGF mRNA levels were determined by Northern analysis. The 
same blot was stripped and hybridized with a control actin probe. The 
data presented is a 24 h exposure of the VEGF blot. (B) C6 astrocytoma 
were similarly analyzed for VEGF mRNA levels. (C) Decay rates for 
VEGF mRNA in tRPE and C6 astrocytoma cells cultured under 
normoxia (RPE, squares; C6 astrocytoma, circles) and hypoxia (RPE, 
diamonds; C6 astrocytoma, triangles). The RPE experiment was per- 
formed three times and the C6 experiment twice; representative data are 
shown. 
To assess the universality of the hypoxia-induced increase in 
VEGF mRNA stability, VEGF mRNA decay rate was exam- 
ined in a rat C6 astrocytoma cell line grown in hypoxia (Fig. 
4B). Similar to the tRPE cell line, hypoxia led to an approxi- 
mately 10-fold increase in steady-state VEGF mRNA levels 
(compare normoxia nd hypoxia, time '0'). The VEGF mRNA 
was rapidly degraded in cells grown under normal oxygen con- 
ditions; levels were barely detectable after 2 h in the absence of 
transcription. As for the tRPE, hypoxia significantly stabilized 
VEGF mRNA levels (Fig. 4C). 
Cobalt(lI) is a metal which elevates VEGF mRNA to similar 
levels and with similar kinetics as hypoxia [25,26]. As it has been 
proposed that cobalt and hypoxia stimulate gene expression 
through the same mechanisms [25], we examined VEGF 
mRNA decay in the presence of cobalt. As for hypoxia, 15 h 
of cobalt chloride (100/zM) exposure led to a 10-fold increase 
in steady-state (time '0') VEGF mRNA levels but had a mini- 
mal effect on the stability of VEGF mRNA (Fig. 5A and B). 
These results suggest hat, unlike hypoxia, the increases in 
VEGF mRNA associated with cobalt cannot be accounted for 
by mRNA stability alone. 
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Fig. 5. Effect of cobalt chloride treatment on VEGF mRNA stability. 
(A) tRPE were cultured in control media, or media with 100#M cobalt 
chloride for 15 h. Cells were refed with control media supplemented 
with 5 pg/ml actinomycin D, incubated for 0, 1, 2, or 4 h, and total RNA 
was isolated and analyzed for VEGF mRNA levels. The same blot was 
stripped and hybridized with a control actin cDNA probe. (B) Graphic 
representation f the decay rates for VEGF mRNA in control and 
cobalt reated cultures. 
4. Discussion 
We and others have shown that the expression of VEGF is 
induced by low oxygen or hypoxia [3,4]. Using primary cultures 
of hRPE, we have observed a 10- to 15-fold increase in VEGF 
mRNA in cells grown in a low oxygen environment. Similarly, 
we have rendered retinal tissue ischemic (and therefore, hy- 
poxic) and observed an increase in ocular angiogenesis that was 
spatially and temporally correlated with an elevation in VEGF 
levels [9]. We were, therefore, interested in the mechanism 
whereby hypoxia might lead to the dramatic increases in steady 
state levels of VEGF mRNA. As a model for the possible 
mechanism, we looked to studies that had been conducted with 
erythropoietin, the hormone which regulates erythrocyte pro- 
duction. Similarities between the regulation of VEGF and 
erythropoietin gene expression were suggested by the fact that 
the expression of both genes is induced by cobalt chloride. 
Cobalt is suspected to act by forcing an oxygen-sensing heme- 
protein into the deoxy conformation, thereby mimicking hy- 
poxia [13]. Studies to date examining the molecular mechanisms 
controlling erythropoietin levels have focused primarily on 
transcriptional regulation [12,27,28]. 
However, run-on analysis of normal and transformed RPE 
grown in low oxygen revealed minimal transcriptional ctiva- 
tion of the VEGF gene throughout an extensive time course 
(2-15 h). Our confidence in this negative result is strengthened 
by the observation of a significant increase in VEGF transcrip- 
tion by phorbol ester, which has been shown to increase VEGF 
mRNA levels. Since transcriptional ctivation does not appear 
to account for the hypoxia-induced increase in VEGF mRNA, 
we examined the possibility that elevated mRNA levels were the 
result of enhanced mRNA stability. Indeed, analysis of VEGF 
mRNA decay in cells cultured under normoxic and hypoxic 
conditions revealed ramatic differences. When the tRPE cells 
were cultured in normoxia, VEGF transcripts, like the mRNA 
of other cytokines [29], had a relatively short half-life, approx- 
imately 30-60 rain. In contrast, the half-life of VEGF in tRPE 
grown in hypoxia was extended to 8 h. Thus, the increase in 
steady state levels of VEGF mRNA in RPE following hypoxia 
appears to be due, in large part, to a stabilization of VEGF 
transcripts in the face of relatively constant transcriptional rate. 
In a recent report, Minchenko and coworkers [26] suggest a
role for transcriptional ctivation in the hypoxia-induced in- 
crease in VEGF mRNA. Using transient transfections assays 
in HeLa cells, cis-elements, which appear to possess hypoxia- 
and cobalt-responsiveness, were identified in both the 3' and 5' 
flanking regions of the human VEGF gene. The 3' enhancer 
shares limited homology with a sequence previously identified 
in the erythropoietin 3' flanking region. However, because 
there was no demonstration of transcriptional ctivation (i.e. 
run-on analysis) in this report, the relative contribution of tran- 
scription in this system is difficult to assess. Without informa- 
tion on the activity of the proposed trans-activating complexes 
in the context of normal chromatin architecture, results ob- 
tained by splicing gene fragments to reporter genes must be 
interpreted with caution. 
Our data suggest an extremely modest role for transcrip- 
tional activation of the VEGF gene in tRPE, but instead indi- 
cate that hypoxia-induction f VEGF mRNA occurs predomi- 
nantly via changes in mRNA stability. It is possible that VEGF 
regulation differs among cell lines or species and that transcrip- 
tional activation may contribute to the hypoxic induction of 
VEGF mRNA in different experimental systems. However, our 
observation i rat C6 astrocytoma (the cells used in early stud- 
ies demonstrating hypoxic induction of VEGF [3]) of hypoxia- 
induced stabilization of VEGF mRNA comparable to that ob- 
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served in the RPE cells, supports a general role for hypoxia- 
induced mRNA stability. 
The observation that cobalt chloride treatment leads to ele- 
vated VEGF mRNA has led others to conclude that cobalt and 
hypoxia act via the same mechanisms to increase the steady 
state levels of VEGF mRNA [25]. Our finding that the cobalt- 
induced increase in steady state levels of VEGF mRNA is not 
associated with significant VEGF mRNA stabilization distin- 
guishes the effects of cobalt from those of hypoxia. Cobalt (II) 
has pleiotropic effects on tissues and cultured cells, including 
generation of reactive oxygen species that lead to DNA damage 
[30,31], lipid peroxidation [32] and metabolic dysfunction [33]. 
Taken together, these data suggest hat cobalt and hypoxia 
exert their effects on VEGF through separate, though poten- 
tially overlapping pathways. 
mRNA stability has been well-documented to play a role in 
the regulation of transferrin receptor levels [34,35] and provides 
the best-studied paradigm of inducible mRNA stability to date. 
Transferrin receptor synthesis is depressed when iron is plenti- 
ful and is elevated when iron levels are reduced. The effects of 
iron on transferrin mRNA have been shown to be mediated 
primarily via a sequence in the 3' UTR of the mRNA [36]. 
Sequence of the VEGF 3'UTR is not yet available so it is not 
possible to make predictions regarding secondary structure(s) 
which might influence message stability. Although sequences in
the 5' flanking region of transferrnin have been shown to medi- 
ate a 2- to 3-fold increase in transferrin receptor transcription 
in iron-deficient cells, deletion of the 3' UTR sequence limi- 
nates the majority of iron regulation even if the promoter is left 
intact. Thus, VEGF and the transferrin receptor may be similar 
in this regard; although there appear to be elements which are 
able to confer hypoxia-induced transcriptional control, regula- 
tion, at least under the conditions of our experiments, is pre- 
dominantly at the level of mRNA stability. 
Regulation of VEGF mRNA at the level of stability seems 
logical in light of the proposed function of this factor as an 
initiator of angiogenesis. Blood vessels, ordinarily quiescent 
tissues, undergo swift, controlled bursts of growth during such 
physiological processes as corpus luteal maturation and wound 
healing. High turnover of growth related mRNA's,  such as 
VEGF, provides an exquisitely responsive system [37]. We pos- 
tulate that hypoxia-induced increases in mRNA stability permit 
the sustained increases in VEGF mRNA levels required to 
support a neovascular response. 
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